157 related articles for article (PubMed ID: 21474590)
21. Signal transducer and activator of transcription (Stat)-6-dependent, but not Stat4-dependent, immunity is required for the development of autoimmunity in Graves' hyperthyroidism.
Land KJ; Moll JS; Kaplan MH; Seetharamaiah GS
Endocrinology; 2004 Aug; 145(8):3724-30. PubMed ID: 15117875
[TBL] [Abstract][Full Text] [Related]
22. Low-dose immunization with adenovirus expressing the thyroid-stimulating hormone receptor A-subunit deviates the antibody response toward that of autoantibodies in human Graves' disease.
Chen CR; Pichurin P; Chazenbalk GD; Aliesky H; Nagayama Y; McLachlan SM; Rapoport B
Endocrinology; 2004 Jan; 145(1):228-33. PubMed ID: 14576177
[TBL] [Abstract][Full Text] [Related]
23. Induction of experimental autoimmune Graves' disease in BALB/c mice.
Kaithamana S; Fan J; Osuga Y; Liang SG; Prabhakar BS
J Immunol; 1999 Nov; 163(9):5157-64. PubMed ID: 10528222
[TBL] [Abstract][Full Text] [Related]
24. Differential requirement of signal transducer and activator of transcription-4 (Stat4) and Stat6 in a thyrotropin receptor-289-adenovirus-induced model of Graves' hyperthyroidism.
Land KJ; Gudapati P; Kaplan MH; Seetharamaiah GS
Endocrinology; 2006 Jan; 147(1):111-9. PubMed ID: 16195404
[TBL] [Abstract][Full Text] [Related]
25. Adoptive transfer of antithyrotropin receptor (TSHR) autoimmunity from TSHR knockout mice to athymic nude mice.
Nakahara M; Johnson K; Eckstein A; Taguchi R; Yamada M; Abiru N; Nagayama Y
Endocrinology; 2012 Apr; 153(4):2034-42. PubMed ID: 22334716
[TBL] [Abstract][Full Text] [Related]
26. Generation of a transgenic animal model of hyperthyroid Graves' disease.
Kim-Saijo M; Akamizu T; Ikuta K; Iida Y; Ohmori K; Matsubara K; Matsuda Y; Suzuki M; Matsuda F; Nakao K
Eur J Immunol; 2003 Sep; 33(9):2531-8. PubMed ID: 12938229
[TBL] [Abstract][Full Text] [Related]
27. Differential Susceptibility of BALB/c and BALB/cBy mice to Graves' hyperthyroidism.
Seetharamaiah GS; Land KJ
Thyroid; 2006 Jul; 16(7):651-8. PubMed ID: 16889488
[TBL] [Abstract][Full Text] [Related]
28. [Progress in the pathogenesis of Graves' disease: approaches from animal models].
Nagayama Y
Nihon Rinsho; 2006 Dec; 64(12):2215-8. PubMed ID: 17154081
[TBL] [Abstract][Full Text] [Related]
29. HLA-DR3 transgenic mice immunized with adenovirus encoding the thyrotropin receptor: T cell epitopes and functional analysis of the CD40 Graves' polymorphism.
Pichurin P; Pham N; David CS; Rapoport B; McLachlan SM
Thyroid; 2006 Dec; 16(12):1221-7. PubMed ID: 17199432
[TBL] [Abstract][Full Text] [Related]
30. Graves' hyperthyroidism and the hygiene hypothesis in a mouse model.
Nagayama Y; McLachlan SM; Rapoport B; Oishi K
Endocrinology; 2004 Nov; 145(11):5075-9. PubMed ID: 15308620
[TBL] [Abstract][Full Text] [Related]
31. "Hijacking" the thyrotropin receptor: A chimeric receptor-lysosome associated membrane protein enhances deoxyribonucleic acid vaccination and induces Graves' hyperthyroidism.
Pichurin PN; Chazenbalk GD; Aliesky H; Pichurina O; Rapoport B; McLachlan SM
Endocrinology; 2004 Dec; 145(12):5504-14. PubMed ID: 15331574
[TBL] [Abstract][Full Text] [Related]
32. A novel murine model of Graves' hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor.
Nagayama Y; Kita-Furuyama M; Ando T; Nakao K; Mizuguchi H; Hayakawa T; Eguchi K; Niwa M
J Immunol; 2002 Mar; 168(6):2789-94. PubMed ID: 11884447
[TBL] [Abstract][Full Text] [Related]
33. Induction of hyperthyroidism in mice by intradermal immunization with DNA encoding the thyrotropin receptor.
Barrett K; Liakata E; Rao PV; Watson PF; Weetman AP; Lymberi P; Banga JP; Carayanniotis G
Clin Exp Immunol; 2004 Jun; 136(3):413-22. PubMed ID: 15147342
[TBL] [Abstract][Full Text] [Related]
34. An improved Graves' disease model established by using in vivo electroporation exhibited long-term immunity to hyperthyroidism in BALB/c mice.
Kaneda T; Honda A; Hakozaki A; Fuse T; Muto A; Yoshida T
Endocrinology; 2007 May; 148(5):2335-44. PubMed ID: 17255207
[TBL] [Abstract][Full Text] [Related]
35. Graves' disease: xenotransplantation model (athymic nude mice).
Jungheim K; Schumm-Draeger PM; Usadel KH
J Mol Med (Berl); 1999 Jan; 77(1):185-8. PubMed ID: 9930960
[TBL] [Abstract][Full Text] [Related]
36. Exacerbation of autoimmune thyroiditis by a single low dose of whole-body irradiation in non-obese diabetic-H2h4 mice.
Nagayama Y; Kaminoda K; Mizutori Y; Saitoh O; Abiru N
Int J Radiat Biol; 2008 Sep; 84(9):761-9. PubMed ID: 18821390
[TBL] [Abstract][Full Text] [Related]
37. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.
Hashizume K; Ichikawa K; Sakurai A; Suzuki S; Takeda T; Kobayashi M; Miyamoto T; Arai M; Nagasawa T
N Engl J Med; 1991 Apr; 324(14):947-53. PubMed ID: 1900575
[TBL] [Abstract][Full Text] [Related]
38. Probing the genetic basis for thyrotropin receptor antibodies and hyperthyroidism in immunized CXB recombinant inbred mice.
Aliesky HA; Pichurin PN; Chen CR; Williams RW; Rapoport B; McLachlan SM
Endocrinology; 2006 Jun; 147(6):2789-800. PubMed ID: 16543368
[TBL] [Abstract][Full Text] [Related]
39. Induction of murine neonatal tolerance against Graves' disease using recombinant adenovirus expressing the TSH receptor A-subunit.
Wu L; Xun L; Yang J; Xu L; Tian Z; Gao S; Zhang Y; Hou P; Shi B
Endocrinology; 2011 Mar; 152(3):1165-71. PubMed ID: 21285313
[TBL] [Abstract][Full Text] [Related]
40. Evidence that factors other than particular thyrotropin receptor T cell epitopes contribute to the development of hyperthyroidism in murine Graves' disease.
Pichurin PN; Chen CR; Nagayama Y; Pichurina O; Rapoport B; McLachlan SM
Clin Exp Immunol; 2004 Mar; 135(3):391-7. PubMed ID: 15008970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
